A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
For adults with diabetes, cycling is associated with reduced all-cause and cardiovascular disease (CVD) mortality.
Investigators report findings from the Dapagliflozin and Prevention of Adverse outcomes in CKD (DAPA-CKD) study.
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Regular antidepressant use is associated with a lower risk for diabetes complications among adults with depression and newly treated diabetes.
Investigators report that continuous treatment is important to ensure that the benefits are not lost due to recurrent NV activity.”
Nevro’s SCS system for painful diabetic neuropathy will be available under the brand name HFX™ for PDN.
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
The researchers examined the relationships of T2D all-cause mortality and myocardial infarction with prior HbA1c values and explored the potential impact of instituting earlier glucose-lowering therapy.
While diabetes-related outpatient visits and testing fell during the pandemic, there was no negative association with medication fills or glycemic control among US adults with diabetes.